UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December, 2019
Commission File Number: 001-13742
ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F | X | Form 40-F |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes | No | X |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes | No | X |
ISRAEL CHEMICALS LTD.
INCORPORATION BY REFERENCE
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of Israel Chemicals Ltd. filed with the Israel Securities Authority and dated March 4, 2019 (Filing Number: 2019-02-018507) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
ISRAEL CHEMICALS LTD.
1. | Final determination by the ITC – ICL Magnesium Imports to the US Did Not Cause Injury |
Item 1
Final determination by the ITC – ICL Magnesium Imports to the US Did Not Cause Injury
Further to Note 6.2 of the Company's financial statements for the third quarter of 2019, regarding the petition filed in the US requesting to impose anti-dumping and countervailing duties on imports of magnesium from Israel, the Company hereby reports that today the International Trade Commission (hereinafter "ITC") unanimously resolved that no material injury or threat of injury has been caused to the US magnesium industry.
The ITC decision brings to an end the administrative investigation against the import of magnesium produced in Israel to the US, and terminates the customs duty rates set by the US Department of Commerce.
For additional information, please refer to note 6.2 to the Company's Q3 report for 2019, filed on November 7, 2019, (Ref. No: 2019-02-108856) and to note 20 to the Company's annual financial statements for 2018, filed on February 27,2019, (Ref No:2019-02-017634).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Israel Chemicals Ltd. | |||||
By: | /s/ Kobi Altman | ||||
Name: | Kobi Altman | ||||
Title: | Chief Financial Officer |
Israel Chemicals Ltd. | |||||
By: | /s/ Aya Landman | ||||
Name: | Aya Landman | ||||
Title: | Global Corporate Secretary |
Date: December 18, 2019